Sera Prognostics, Inc. logo

Sera Prognostics, Inc.

NASDAQ:SERA

Overview | Financials
Company Name Sera Prognostics, Inc.
Symbol SERA
Currency USD
Price 7.25
Market Cap 234,905,793
Dividend Yield 0%
52-week-range 1.52 - 12.355
Industry Diagnostics & Research
Sector Healthcare
CEO Ms. Evguenia Lindgardt M.B.A.
Website https://seraprognostics.com

An error occurred while fetching data.

About Sera Prognostics, Inc.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various

Related Stocks

BeyondSpring Inc. logo

BeyondSpring Inc.

BYSI

1.97 USD

ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V.

PRQR

1.855 USD

MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc.

INKT

0.788 USD

Freeline Therapeutics Holdings plc logo

Freeline Therapeutics Holdings plc

FRLN

6.49 USD

BioSig Technologies, Inc. logo

BioSig Technologies, Inc.

BSGM

0.41 USD

Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc.

CRVS

4.03 USD

Syros Pharmaceuticals, Inc. logo

Syros Pharmaceuticals, Inc.

SYRS

1.515 USD

Financials

Numbers are in millions USD

Numbers are in millions USD